This event is back in-person on January 9-11, but will also be arranged as a virtual event a few days later.
The program will feature insights from top investors and biopharma executives by examining how the biopharma industry can accelerate drug discovery and manufacturing to prepare for future pandemics, providing updates in hot therapeutic areas such as oncology, CNS, cell and gene therapy, rare disease, exploring how COVID-19 accelerated the adoption of all things digital through the Digital Medicine & Medtech Showcase program, and showcasing the promise of early-stage innovation through the Seed Showcase program.
The 2023 program will feature financing and business topics including The decision to launch your own: critical success factors, Royalty licenses: an economic asset often ignored and Early seed financing: what are the best funding strategies for biotech start-ups, but also in-depth sessions such as COVID: What to expect next, Cardiometabolic syndrome: the largest global threat to mortality and Next-generation therapies to fight cancer. Decentralized clinical trials will also be discussed, as well as the Biden policy’s impact on the biopharma sector.
Read more about Biotech Showcase 2023 here!